The outcomes indicate that Core Laboratories’ shareholders are in agreement with the board’s recommendations on these key issues.

HOUSTON - Core Laboratories Inc. (NYSE:CLB), a provider of reservoir optimization technologies with a market capitalization of $547.59 million and annual revenue of $517.8 million, has launched a new ...

--Core Laboratories Inc. is pleased to announce the opening of its new Unconventional Core Analysis Laboratory in Dammam, Kingdom of Saudi Arabia. This state-of-the-art facility, developed in ...

Core Laboratories Inc. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance.

Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") is pleased to announce the opening of its new Unconventional Core Analysis Laboratory in Dammam, Kingdom of Saudi Arabia ...

Core Laboratories (CLB) delivered earnings and revenue surprises of -6.67% and 0.38%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

HOUSTON (AP) — HOUSTON (AP) — Core Laboratories Inc. (CLB) on Wednesday reported a loss of $154,000 in its first quarter. On a per-share basis, the Houston-based company said it had a loss of ...

Core Laboratories Inc. (NYSE:CLB – Free Report) – Research analysts at Zacks Research decreased their Q2 2025 EPS estimates for shares of Core Laboratories in a research report issued on ...

Charles Schwab Investment Management Inc. lowered its stake in Core Laboratories Inc. (NYSE:CLB – Free Report) by 5.7% during the fourth quarter, according to its most recent 13F filing with the ...

Scottsdale-based HonorHealth Research Institute opened a $7 million Center for Translational Science laboratory at the 850 PBC on the Phoenix Bioscience Core campus in downtown Phoenix.